Crossmark Global Holdings Inc. lifted its position in shares of Bath & Body Works, Inc. (NYSE:BBWI - Free Report) by 314.1% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 103,165 shares of the company's stock after purchasing an additional 78,252 shares during the quarter. Crossmark Global Holdings Inc. owned approximately 0.05% of Bath & Body Works worth $1,642,000 as of its most recent filing with the Securities and Exchange Commission.
Several other institutional investors also recently modified their holdings of BBWI. 1834 Investment Advisors Co. grew its position in Bath & Body Works by 63.8% in the third quarter. 1834 Investment Advisors Co. now owns 316,246 shares of the company's stock valued at $5,035,000 after acquiring an additional 123,222 shares during the period. Kwmg LLC lifted its holdings in shares of Bath & Body Works by 6.7% during the third quarter. Kwmg LLC now owns 246,420 shares of the company's stock valued at $3,923,000 after acquiring an additional 15,421 shares during the period. Moody National Bank Trust Division bought a new position in shares of Bath & Body Works during the third quarter valued at $307,000. QRG Capital Management Inc. boosted its stake in shares of Bath & Body Works by 19.4% in the 2nd quarter. QRG Capital Management Inc. now owns 17,649 shares of the company's stock valued at $408,000 after purchasing an additional 2,871 shares in the last quarter. Finally, Tidal Investments LLC boosted its stake in shares of Bath & Body Works by 3.1% in the 2nd quarter. Tidal Investments LLC now owns 107,852 shares of the company's stock valued at $2,495,000 after purchasing an additional 3,211 shares in the last quarter. Institutional investors and hedge funds own 95.14% of the company's stock.
Bath & Body Works Stock Performance
Shares of NYSE:BBWI opened at $20.96 on Monday. Bath & Body Works, Inc. has a twelve month low of $14.27 and a twelve month high of $27.40. The firm has a market cap of $4.23 billion, a PE ratio of 5.46, a price-to-earnings-growth ratio of 1.05 and a beta of 1.40. The business has a fifty day moving average of $18.31 and a 200-day moving average of $19.13.
Bath & Body Works (NYSE:BBWI - Get Free Report) last released its quarterly earnings results on Wednesday, August 26th. The company reported $0.62 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.24 by $0.38. Bath & Body Works had a negative return on equity of 53.48% and a net margin of 10.83%. The business had revenue of $1.51 billion during the quarter, compared to analysts' expectations of $1.50 billion. During the same period in the previous year, the business posted $0.30 earnings per share. The firm's revenue for the quarter was down 2.3% compared to the same quarter last year. Bath & Body Works has set its Q3 2026 guidance at 0.070-0.120 EPS and its FY 2026 guidance at 2.600-2.800 EPS. On average, analysts anticipate that Bath & Body Works, Inc. will post 2.73 EPS for the current fiscal year.
Bath & Body Works Announces Dividend
The business also recently announced a quarterly dividend, which was paid on Friday, September 4th. Shareholders of record on Friday, August 21st were paid a $0.20 dividend. The ex-dividend date of this dividend was Friday, August 21st. This represents a $0.80 dividend on an annualized basis and a dividend yield of 3.8%. Bath & Body Works's payout ratio is currently 20.83%.
Analysts Set New Price Targets
Several equities research analysts have recently weighed in on BBWI shares. JPMorgan Chase & Co. upped their target price on shares of Bath & Body Works from $22.00 to $24.00 and gave the stock a "neutral" rating in a report on Tuesday, August 18th. Barclays reduced their price target on shares of Bath & Body Works from $23.00 to $22.00 and set an "equal weight" rating on the stock in a research report on Thursday, August 27th. UBS Group decreased their price objective on shares of Bath & Body Works from $19.00 to $17.00 and set a "neutral" rating on the stock in a research note on Thursday, August 27th. Morgan Stanley decreased their price objective on shares of Bath & Body Works from $22.00 to $20.00 and set an "equal weight" rating on the stock in a research note on Thursday, August 27th. Finally, Robert W. Baird dropped their price objective on shares of Bath & Body Works from $25.00 to $23.00 and set a "neutral" rating for the company in a report on Thursday, August 27th. Four equities research analysts have rated the stock with a Buy rating, fifteen have issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of "Hold" and a consensus price target of $22.13.
Read Our Latest Research Report on BBWI
About Bath & Body Works
(
Free Report)
Bath & Body Works, Inc is a specialty retailer focused on personal care and home fragrance products. Its merchandise includes body lotions, shower gels, fragrances, soaps, hand sanitizers, candles, air fresheners and other fragrance-focused items sold under the Bath & Body Works brand.
The company operates through a network of retail stores and digital commerce channels, serving customers primarily in the United States and Canada. Its products are also available internationally through select partners, including franchise, wholesale and other distribution arrangements.
Bath & Body Works traces its origins to 1990 and was formerly part of L Brands, Inc The company became an independent publicly traded business in 2021 after separating from L Brands.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Bath & Body Works, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bath & Body Works wasn't on the list.
While Bath & Body Works currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.